Orkla India Limited has received the necessary regulatory approvals for an
initial public offering of its equity shares on the Indian stock exchanges and
has filed the red herring prospectus dated 23 October 2025 with the Indian
regulators.
As announced in the stock exchange notice of 11 June 2025, Orkla India Limited
("Orkla India") filed a draft red herring prospectus dated 10 June 2025 with
the Securities and Exchange Board of India ("SEBI"), BSE Limited ("BSE") and
National Stock Exchange of India Limited ("NSE" and together with BSE as the
"Indian Stock Exchanges") in connection with a proposed initial public
offering of its equity shares of the face value of INR 1 each ("Equity Shares"
and the initial public offering by Orkla India as the "Offer").
Orkla India has now filed the red herring prospectus dated 23 October 2025
("RHP") with the Registrar of Companies, Karnataka at Bengaluru and
subsequently with SEBI and the Indian Stock Exchanges.
The Offer, as described in the RHP, comprises an offer for sale of up to
22,843,004 Equity Shares ("Offered Shares"), undertaken by Orkla Asia Pacific
Pte. Ltd., an indirect wholly owned subsidiary of Orkla ASA, and certain other
eligible shareholders of Orkla India. Orkla Asia Pacific Pte. Ltd. is offering
up to 20,560,768 Equity Shares, representing approximately 90% of the total
number of Offered Shares.
The Bid/Offer Period is from Wednesday, 29 October 2025 to Friday, 31 October
2025. The Anchor Investor Bidding Date is Tuesday, 28 October, 2025. The Price
Band for the Offered Shares ranges from the Floor Price of INR 695 per Equity
Share (approximately NOK 79 per Equity Share) to the Cap Price of INR 730 per
Equity Share (approximately NOK 83 per Equity Share) (the "Price Band").
Subject to receipt of final listing and trading approvals from the Indian
Stock Exchanges, the trading of the Equity Shares of Orkla India on the Indian
Stock Exchanges will commence on or about Thursday, 6 November 2025.
All capitalized terms used but not specifically defined here will have the
same meaning as mentioned in the RHP and the Price Band advertisement. The RHP
and Price Band advertisement are available on the Orkla India website:
https://www.orklaindia.com.
Orkla ASA
Oslo, 24 October 2025
Ref.:
SVP Investor Relations & Communication
Annie Bersagel
Tel.: +47 986 03 664
Not for distribution in the United States of America, Canada, Australia or
Japan or in any other jurisdiction in which such distribution or dissemination
would be prohibited by applicable law. This notice is not being made available
in, and is not for release, publication or distribution, directly or
indirectly, in whole or in part, in or into the United States of America,
Canada, Australia or Japan or any other jurisdiction in which such
distribution or dissemination would be prohibited by applicable law. This
announcement is for informational purposes only and is not intended, and
should not be construed, as an offer of, or a solicitation of an offer to buy,
securities in the United States or any other jurisdiction. The securities
described herein have not been and will not be registered under the United
States Securities Act of 1933 (the U.S. Securities Act), or the laws of any
state of the United States, and may not be offered or sold within the United
States, except pursuant to an exemption from, or in a transaction not subject
to, the registration requirements of the U.S. Securities Act and in compliance
with all applicable state laws. There will be no public offering of such
securities in the United States.
This information is subject to disclosure under the Norwegian Securities
Trading Act, ยง5-12. The information was submitted for publication at
2025-10-24 08:00 CEST.